Vemurafenib Terminated Phase 1 Trials for Stage IIIB Melanoma / Stage IIIc Melanoma / Stage IV Melanoma / Unspecified Adult Solid Tumor, Protocol Specific / Stage IIIA Melanoma / Recurrent Melanoma Treatment

IndicationsStatusPurposePhase
TerminatedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01835184Cabozantinib-S-Malate and Vemurafenib in Treating Patients With Solid Tumors or Melanoma That is Metastatic or That Cannot Be Removed By Surgery